Suppr超能文献

深入了解新兴致病性酵母耳念珠菌东亚分支的独特性质。

Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris.

机构信息

Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia, USA

Mycotic Diseases Branch, Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.

出版信息

J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.00007-19. Print 2019 Apr.

Abstract

The emerging yeast can be highly drug resistant, causing invasive infections, and large outbreaks. went from an unknown pathogen a decade ago to being reported in over thirty countries on six continents. consists of four discrete clades, based on where the first isolates of the clade were reported, South Asian (clade I), East Asian (clade II), African (clade III), and South American (clade IV). These clades have unique genetic and biochemical characteristics that are important to understand and inform the global response to Clade II has been underrepresented in the literature despite being the first one discovered. In this issue of the , Y. J. Kwon et al. (J Clin Microbiol 57:e01624-18, 2019, https://doi.org/10.1128/JCM.01624-18) describe the largest collection of clinical isolates from Clade II, which is also the longest-running span of clinical cases, 20 years, from any single region to date. Clade II appears to have a propensity for the ear that is uncharacteristic of the other clades, which typically cause invasive infections and large-scale outbreaks. This study provides new information on an understudied lineage of and has important implications for future surveillance.

摘要

新兴的酵母可能具有高度的耐药性,导致侵袭性感染和大规模爆发。该酵母在十年前还是一种未知病原体,如今已在六大洲的三十多个国家报告。它由四个离散的进化枝组成,基于进化枝的第一个分离株报告的地点,分别是南亚(进化枝 I)、东亚(进化枝 II)、非洲(进化枝 III)和南美(进化枝 IV)。这些进化枝具有独特的遗传和生化特征,了解这些特征对于指导全球应对该酵母的策略非常重要。尽管进化枝 II 是最早被发现的,但它在文献中的代表性不足。在本期的《临床微生物学杂志》上,Y. J. Kwon 等人(J Clin Microbiol 57:e01624-18, 2019, https://doi.org/10.1128/JCM.01624-18)描述了来自进化枝 II 的最大临床分离株集,这也是迄今为止来自任何单一地区最长的临床病例跨度,持续了 20 年。进化枝 II 似乎有一种不同于其他进化枝的耳部倾向性,其他进化枝通常会导致侵袭性感染和大规模爆发。本研究提供了关于该酵母一个研究不足的谱系的新信息,对未来的监测具有重要意义。

相似文献

1
Insights into the Unique Nature of the East Asian Clade of the Emerging Pathogenic Yeast Candida auris.
J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.00007-19. Print 2019 Apr.
2
Emergence of the novel sixth Clade VI in Bangladesh.
Microbiol Spectr. 2024 Jul 2;12(7):e0354023. doi: 10.1128/spectrum.03540-23. Epub 2024 Jun 6.
5
Detection and characterisation of a sixth Candida auris clade in Singapore: a genomic and phenotypic study.
Lancet Microbe. 2024 Sep;5(9):100878. doi: 10.1016/S2666-5247(24)00101-0. Epub 2024 Jul 13.
6
Analysis of a Candida auris Outbreak Provides New Insights into an Emerging Pathogen.
J Clin Microbiol. 2020 Mar 25;58(4). doi: 10.1128/JCM.02083-19.
7
Candida auris in Singapore: Genomic epidemiology, antifungal drug resistance, and identification using the updated 8.01 VITEK2 system.
Int J Antimicrob Agents. 2019 Dec;54(6):709-715. doi: 10.1016/j.ijantimicag.2019.09.016. Epub 2019 Oct 7.
9
Four genomic clades of Candida auris identified in Canada, 2012-2019.
Med Mycol. 2022 Jan 10;60(1). doi: 10.1093/mmy/myab079.
10
Clade distribution of in South Africa using whole genome sequencing of clinical and environmental isolates.
Emerg Microbes Infect. 2021 Dec;10(1):1300-1308. doi: 10.1080/22221751.2021.1944323.

引用本文的文献

2
: A Continuing Threat.
Microorganisms. 2025 Mar 13;13(3):652. doi: 10.3390/microorganisms13030652.
3
The multidrug-resistant complex and phylogenetic related species: Insights into antifungal resistance mechanisms.
Curr Res Microb Sci. 2025 Jan 28;8:100354. doi: 10.1016/j.crmicr.2025.100354. eCollection 2025.
5
A simple and sensitive test for colonization, surveillance, and infection control suitable for near patient use.
J Clin Microbiol. 2024 Jul 16;62(7):e0052524. doi: 10.1128/jcm.00525-24. Epub 2024 Jun 18.
7
The many faces of Candida auris: Phenotypic and strain variation in an emerging pathogen.
PLoS Pathog. 2024 Mar 1;20(3):e1012011. doi: 10.1371/journal.ppat.1012011. eCollection 2024 Mar.
8
Impact of Micafungin on Candida auris β-glucan Masking and Neutrophil Interactions.
J Infect Dis. 2024 Sep 23;230(3):763-767. doi: 10.1093/infdis/jiae043.
10
Tools and techniques to identify, study, and control Candida auris.
PLoS Pathog. 2023 Oct 19;19(10):e1011698. doi: 10.1371/journal.ppat.1011698. eCollection 2023 Oct.

本文引用的文献

1
Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping.
J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.01624-18. Print 2019 Apr.
3
Candida auris in South Africa, 2012-2016.
Emerg Infect Dis. 2018 Nov;24(11):2036-2040. doi: 10.3201/eid2411.180368.
4
Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey.
Lancet Infect Dis. 2018 Dec;18(12):1377-1384. doi: 10.1016/S1473-3099(18)30597-8. Epub 2018 Oct 4.
5
Candida auris: a global fungal public health threat.
Lancet Infect Dis. 2018 Dec;18(12):1298-1299. doi: 10.1016/S1473-3099(18)30609-1. Epub 2018 Oct 4.
6
Candida auris in Healthcare Facilities, New York, USA, 2013-2017.
Emerg Infect Dis. 2018 Oct;24(10):1816-1824. doi: 10.3201/eid2410.180649.
7
Candida auris: The recent emergence of a multidrug-resistant fungal pathogen.
Med Mycol. 2019 Jan 1;57(1):1-12. doi: 10.1093/mmy/myy054.
8
Rapid Detection of Candida auris Based on Loop-Mediated Isothermal Amplification (LAMP).
J Clin Microbiol. 2018 Aug 27;56(9). doi: 10.1128/JCM.00591-18. Print 2018 Sep.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验